Sayre Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.03 M
- Paid Up Capital ₹ 2.88 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 36.50 Cr
- Satisfied Charges ₹ 18.30 Cr
- Revenue Growth 22.31%
- Profit Growth 43.78%
- Ebitda 126.25%
- Net Worth -3.49%
- Total Assets 10.59%
About Sayre Therapeutics
Sayre Therapeutics Private Limited (STPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 07 April 2015 (Nine years and ten months 17 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.03 M and a paid-up capital of Rs 2.88 M.
The company currently has active open charges totaling ₹36.50 Cr. The company has closed loans amounting to ₹18.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahendran Balachandran, Shukrit Chimote, and Sasidharan Rajesh serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110KA2015PTC079687
- Company No.
079687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sayre Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shukrit Chimote  | Director | 07-Apr-2015 | Current |
| Mahendran Balachandran | Director | 30-Jun-2015 | Current |
| Sasidharan Rajesh | Director | 23-Dec-2021 | Current |
Financial Performance of Sayre Therapeutics.
Sayre Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.31% increase. The company also saw a substantial improvement in profitability, with a 43.78% increase in profit. The company's net worth dipped by a decrease of 3.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sayre Therapeutics?
In 2023, Sayre Therapeutics had a promoter holding of 86.44% and a public holding of 13.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Probe Information Services Private LimitedMahendran Balachandran is a mutual person
Power2sme Private LimitedMahendran Balachandran is a mutual person
Accel India Advisors LlpMahendran Balachandran is a mutual person
- Accel India Management Llp
Mahendran Balachandran is a mutual person
Wrogn Private LimitedMahendran Balachandran is a mutual person
Charges (Loans)
₹365.00 M
₹183.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 18.00 Cr
- Others : 10.00 Cr
- Hdfc Bank Limited : 8.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2023 | Axis Bank Limited | ₹18.00 Cr | Open |
| 29 Nov 2021 | Hdfc Bank Limited | ₹8.50 Cr | Open |
| 26 Jul 2021 | Others | ₹10.00 Cr | Open |
| 29 Apr 2019 | Hdfc Bank Limited | ₹6.30 Cr | Satisfied |
| 27 Dec 2017 | Hdfc Bank Limited | ₹5.00 Cr | Satisfied |
How Many Employees Work at Sayre Therapeutics?
Sayre Therapeutics has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sayre Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sayre Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
